Sana Biotechnology Inc
(SANA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -355,928 | -245,197 | -161,934 | -180,617 | -285,305 |
| Depreciation Amortization | 11,070 | 7,735 | 4,853 | 2,247 | 5,921 |
| Accounts payable and accrued liabilities | -266 | 1,397 | -373 | 1,599 | 1,982 |
| Other Working Capital | 9,801 | 11,338 | 5,672 | -3,136 | 6,156 |
| Other Operating Activity | 84,269 | 83,772 | 61,313 | 129,994 | 133,264 |
| Operating Cash Flow | $-251,054 | $-140,955 | $-90,469 | $-49,913 | $-137,982 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -29,862 | -24,660 | -16,596 | -6,440 | -23,872 |
| Purchase Of Investment | -491,387 | -414,437 | -165,551 | -44,811 | -387,432 |
| Sale Of Investment | 280,025 | 266,960 | 195,914 | 100,342 | 158,741 |
| Other Investing Activity | -4,574 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-245,798 | $-172,137 | $13,767 | $49,091 | $-252,563 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 631,751 | 628,632 | 627,036 | 626,703 | 149 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 435,538 |
| Financing Cash Flow | $631,751 | $628,632 | $627,036 | $626,703 | $435,687 |
| Beginning Cash Position | 126,949 | 126,949 | 126,949 | 126,949 | 81,807 |
| End Cash Position | 261,848 | 442,489 | 677,283 | 752,830 | 126,949 |
| Net Cash Flow | $134,899 | $315,540 | $550,334 | $625,881 | $45,142 |
| Free Cash Flow | |||||
| Operating Cash Flow | -251,054 | -140,955 | -90,469 | -49,913 | -137,982 |
| Capital Expenditure | -29,862 | -24,660 | -16,596 | -6,440 | -23,872 |
| Free Cash Flow | -280,916 | -165,615 | -107,065 | -56,353 | -161,854 |